NasdaqGS - Delayed Quote USD

Health Catalyst, Inc. (HCAT)

4.0600
-0.0500
(-1.22%)
At close: May 16 at 4:00:01 PM EDT
4.0500
-0.01
(-0.25%)
After hours: May 16 at 5:50:18 PM EDT
Loading Chart for HCAT
  • Previous Close 4.1100
  • Open 4.1000
  • Bid 2.9400 x 200
  • Ask 5.1000 x 200
  • Day's Range 3.9850 - 4.1650
  • 52 Week Range 3.5550 - 9.2400
  • Volume 374,996
  • Avg. Volume 729,316
  • Market Cap (intraday) 285.713M
  • Beta (5Y Monthly) 1.57
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1400
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.09

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

www.healthcatalyst.com

1,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HCAT

View More

Performance Overview: HCAT

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HCAT
42.57%
S&P 500 (^GSPC)
1.30%

1-Year Return

HCAT
42.25%
S&P 500 (^GSPC)
12.48%

3-Year Return

HCAT
72.27%
S&P 500 (^GSPC)
48.66%

5-Year Return

HCAT
85.84%
S&P 500 (^GSPC)
108.07%

Compare To: HCAT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HCAT

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    282.58M

  • Enterprise Value

    342.98M

  • Trailing P/E

    --

  • Forward P/E

    19.34

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    0.75

  • Enterprise Value/Revenue

    1.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.34%

  • Return on Assets (ttm)

    -4.15%

  • Return on Equity (ttm)

    -19.80%

  • Revenue (ttm)

    311.27M

  • Net Income Avi to Common (ttm)

    -72.66M

  • Diluted EPS (ttm)

    -1.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    341.97M

  • Total Debt/Equity (mrq)

    106.78%

  • Levered Free Cash Flow (ttm)

    22.18M

Research Analysis: HCAT

View More

Company Insights: HCAT

Research Reports: HCAT

View More

People Also Watch